Description

The Morcher 67B Aniridia IOL is a specialized intraocular lens implant designed to address significant iris defects, such as those caused by aniridia. Crafted by Morcher, this innovative device serves a dual purpose, providing both light occlusion and visual rehabilitation for patients in need of comprehensive iris reconstruction.

Key Features

• Size and Design: The implant measures 12.5 mm with a 3-mm optic, making it suitable for precise placement in the eye's sulcus or for scleral suturing. This design ensures that the lens can effectively mimic the natural function of an iris while also serving as a visual aid.

• Combination Device: As a combination artificial iris and lens, the Morcher 67B offers a unique solution for those requiring both functional and cosmetic improvement of the iris.

Optic Variability

The optics of the Morcher 67B are available in various diameters, allowing for customization to meet individual patient needs. This adaptability is crucial for achieving the desired visual outcomes and enhancing the overall effectiveness of the implant.

Color and Aesthetic Considerations

The implant is available in black, which may be more noticeable in patients with lighter-colored irises. While this color limitation may affect cosmetic outcomes, the primary focus remains on restoring essential iris functions.

Availability and Regulatory Status

The Morcher 67B Aniridia IOL is not FDA approved and is available in the United States only through clinical trials or compassionate use exemptions. This regulatory status underscores the specialized nature of the device and its targeted application for patients with specific medical needs.

Intended Audience

This implant is intended for patients with large iris defects who require both functional and cosmetic reconstruction of the iris. By addressing these needs, the Morcher 67B plays a vital role in enhancing visual quality and improving the quality of life for individuals with significant iris abnormalities.